Literature DB >> 17675397

Complete cerebral response with sunitinib for metastatic renal cell carcinoma.

J Medioni, O Cojocarasu, J-L Belcaceres, P Halimi, S Oudard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17675397     DOI： 10.1093/annonc/mdm275

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  24 in total

1.  Which patients with renal cancer may benefit from sunitinib therapy?

Authors:  Tom Ferguson; Martin Gore
Journal:  Ther Adv Med Oncol       Date:  2010-03       Impact factor: 8.168

Review 2.  Targeted therapies in renal cell cancer: recent developments in imaging.

Authors:  Astrid A M van der Veldt; Martijn R Meijerink; Alfons J M van den Eertwegh; Epie Boven
Journal:  Target Oncol       Date:  2010-07-14       Impact factor: 4.493

3.  Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study.

Authors:  Steven G Dubois; Suzanne Shusterman; Ashish M Ingle; Charlotte H Ahern; Joel M Reid; Bing Wu; Sylvain Baruchel; Julia Glade-Bender; Percy Ivy; Holcombe E Grier; Peter C Adamson; Susan M Blaney
Journal:  Clin Cancer Res       Date:  2011-06-20       Impact factor: 12.531

4.  Progression of intramedullary metastasis during perioperative cessation of sunitinib.

Authors:  Fausto Petrelli; Mary Cabiddu; Marinella Carpo; Mara Ghilardi; Sandro Barni
Journal:  Nat Rev Urol       Date:  2010-10-12       Impact factor: 14.432

5.  Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transporters.

Authors:  Shuiying Hu; Zhaoyuan Chen; Ryan Franke; Shelley Orwick; Ming Zhao; Michelle A Rudek; Alex Sparreboom; Sharyn D Baker
Journal:  Clin Cancer Res       Date:  2009-09-22       Impact factor: 12.531

6.  Does angiogenesis play a role in the establishment of mesial temporal lobe epilepsy?

Authors:  Ruba Benini; Raquel Roth; Zehra Khoja; Massimo Avoli; Pia Wintermark
Journal:  Int J Dev Neurosci       Date:  2016-01-07       Impact factor: 2.457

7.  Imbalance and gait disturbance from tyrosine kinase inhibition in hepatocellular cancer.

Authors:  Rebecca A Miksad; Kuan-Chi Lai; Marion C Stein; Megan E Healy; Rafael Rojas; Katherine M Krajewski; Andrew X Zhu
Journal:  J Gastrointest Cancer       Date:  2009

8.  Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model.

Authors:  Qingyu Zhou; James M Gallo
Journal:  Neuro Oncol       Date:  2008-10-29       Impact factor: 12.300

Review 9.  Oral Targeted Therapies and Central Nervous System (CNS) Metastases.

Authors:  Michael P Gabay; Scott M Wirth; Joan M Stachnik; Colleen L Overley; Katie E Long; Linda R Bressler; John L Villano
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

Review 10.  Expert Recommendations for First-Line Management of Metastatic Renal Cell Carcinoma in Special Subpopulations.

Authors:  Javier Puente; Xavier García Del Muro; Álvaro Pinto; Nuria Láinez; Emilio Esteban; José Ángel Arranz; Enrique Gallardo; María José Méndez; Pablo Maroto; Enrique Grande; Cristina Suárez
Journal:  Target Oncol       Date:  2016-04       Impact factor: 4.493
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.